InMed Pharmaceuticals Inc.
Disclosed SEC business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, V6B 0M3
InMed Pharmaceuticals Inc. (ticker INM, CIK 0001728328) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Every item is grounded on the cited public source — no figures are fabricated.
Go deeper
This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 4 free company deep views left this month.
Sources
- U.S. Securities and Exchange Commission, EDGAR · XBRL company facts · retrieved 2026-10-25T00:12:00.790232+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing index · retrieved 2026-10-19T18:39:28.292507+00:00
- SEC EDGAR · issuer filing index
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.